We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-11.26%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.3B
AUM Growth
+$1.07B
Cap. Flow
+$2.36B
Cap. Flow %
22.99%
Top 10 Hldgs %
47.42%
Holding
1,109
New
276
Increased
252
Reduced
500
Closed
79

Top Buys

Rank Stock Value
1
WES icon
Western Midstream Partners
WES
+$619M
2
CCJ icon
Cameco
CCJ
+$146M
3
HESM icon
Hess Midstream
HESM
+$80.6M
4
VZ icon
Verizon
VZ
+$58.6M
5
MSFT icon
Microsoft
MSFT
+$51.2M

Sector Composition

Rank Sector Weight
1 Energy 60.43%
2 Technology 6.16%
3 Healthcare 4.82%
4 Consumer Discretionary 4.16%
5 Industrials 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNCE
1026
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$93K ﹤0.01%
30,656
-22,468
-42% -$109K
EPIX
1027
DELISTED
ESSA Pharma
EPIX
$82K ﹤0.01%
+26,140
New +$146K
GRAB icon
1028
Grab
GRAB
$13.5B
$37K ﹤0.01%
+14,500
New +$41.6K
SOND
1029
DELISTED
Sonder
SOND
$14K ﹤0.01%
+655
New +$37.3K
MBT
1030
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$1K ﹤0.01%
64,600
ALLK
1031
DELISTED
Allakos
ALLK
-56,324
Closed -$321K
AMSC icon
1032
American Superconductor
AMSC
$1.48B
-174,911
Closed -$1.33M
ANNX icon
1033
Annexon
ANNX
$855M
-39,788
Closed -$109K
ATOS icon
1034
Atossa Therapeutics
ATOS
$22.9M
-8,676
Closed -$163K
ATRA icon
1035
Atara Biotherapeutics
ATRA
$71.2M
-3,827
Closed -$889K
BBJP icon
1036
JPMorgan BetaBuilders Japan ETF
BBJP
$17.3B
-226,750
Closed -$11.5M
BCAB icon
1037
BioAtla
BCAB
$5.59M
-764
Closed -$191K
BIP icon
1038
Brookfield Infrastructure Partners
BIP
$18.8B
-47,475
Closed -$2.1M
BKR icon
1039
Baker Hughes
BKR
$56.8B
-8,685
Closed -$316K
BYSI icon
1040
BeyondSpring
BYSI
$46.1M
-40,560
Closed -$89K
CAT icon
1041
Caterpillar
CAT
$409B
-2,254
Closed -$502K
CHRS icon
1042
Coherus Oncology
CHRS
$217M
-79,420
Closed -$1.02M
CKPT
1043
DELISTED
Checkpoint Therapeutics
CKPT
-8,609
Closed -$152K
CLNN icon
1044
Clene
CLNN
$68.9M
-3,202
Closed -$252K
CRDF icon
1045
Cardiff Oncology
CRDF
$64.3M
-44,511
Closed -$110K
CTMX icon
1046
CytomX Therapeutics
CTMX
$705M
-67,211
Closed -$179K
DE icon
1047
Deere & Co
DE
$170B
-1,025
Closed -$426K
DEI icon
1048
Douglas Emmett
DEI
$2.06B
-12,544
Closed -$419K
DNTH icon
1049
Dianthus Therapeutics
DNTH
$5.68B
-3,777
Closed -$175K
DOUG icon
1050
Douglas Elliman
DOUG
$155M
-31,792
Closed -$221K

Similar funds

ALPS Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, ALPS Advisors held 1,109 positions worth $10.3B, up 12% from $9.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ALPS Advisors deployed $2.36B of net new capital in Q2 2022, opening 276 new positions and adding to 252 existing holdings. Its largest new stake was Western Midstream Partners: 24,175,389 shares worth $588M.

By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Energy Transfer Partners, an estimated $71M trimmed.

  • ALPS Advisors's largest Q2 2022 buy was Western Midstream Partners: 24,175,389 shares worth $588M.
  • ALPS Advisors added most to Hess Midstream in Q2 2022, an estimated $80.6M increase.
  • ALPS Advisors's biggest Q2 2022 reduction was Energy Transfer Partners, cutting an estimated $71M.
  • ALPS Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $23.8M.
  • ALPS Advisors's ten largest holdings make up 47% of its $10.3B portfolio in Q2 2022.
  • ALPS Advisors opened 276 new positions and closed 79 in Q2 2022.
  • ALPS Advisors's portfolio value rose 12% quarter-over-quarter to $10.3B.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.